Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00082524
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2004-05-11
Brief Title:
Documented Candida or Aspergillus Infections in Pediatric Patients 0991-043
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Multicenter Open-Label Noncomparative Study to Evaluate the Safety Tolerability and Efficacy of Caspofungin Acetate in Children With Documented Candida or Aspergillus Infections
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an open label noncomparative study using an investigational agent for the treatment of documented Candida or Aspergillus infections in pediatric patients ages 3 months-17 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004_100 | None | None | None |
| Formerly-0404CCAI | None | None | None |
| MK0991-043 | None | None | None |